6-159969299-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000876.4(IGF2R):c.53G>T(p.Arg18Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000323 in 1,239,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_000876.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGF2R | NM_000876.4 | c.53G>T | p.Arg18Leu | missense_variant | 1/48 | ENST00000356956.6 | NP_000867.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGF2R | ENST00000356956.6 | c.53G>T | p.Arg18Leu | missense_variant | 1/48 | 1 | NM_000876.4 | ENSP00000349437.1 | ||
IGF2R | ENST00000676781.1 | n.53G>T | non_coding_transcript_exon_variant | 1/49 | ENSP00000504419.1 | |||||
IGF2R | ENST00000677704.1 | n.53G>T | non_coding_transcript_exon_variant | 1/49 | ENSP00000503314.1 |
Frequencies
GnomAD3 genomes AF: 0.000133 AC: 20AN: 150172Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000184 AC: 20AN: 1088970Hom.: 0 Cov.: 30 AF XY: 0.0000133 AC XY: 7AN XY: 524348
GnomAD4 genome AF: 0.000133 AC: 20AN: 150280Hom.: 0 Cov.: 33 AF XY: 0.000123 AC XY: 9AN XY: 73398
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2024 | The c.53G>T (p.R18L) alteration is located in exon 1 (coding exon 1) of the IGF2R gene. This alteration results from a G to T substitution at nucleotide position 53, causing the arginine (R) at amino acid position 18 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at